Correlation Between HLB Pharmaceutical and Korean Drug

Can any of the company-specific risk be diversified away by investing in both HLB Pharmaceutical and Korean Drug at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HLB Pharmaceutical and Korean Drug into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HLB Pharmaceutical Co and Korean Drug Co, you can compare the effects of market volatilities on HLB Pharmaceutical and Korean Drug and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HLB Pharmaceutical with a short position of Korean Drug. Check out your portfolio center. Please also check ongoing floating volatility patterns of HLB Pharmaceutical and Korean Drug.

Diversification Opportunities for HLB Pharmaceutical and Korean Drug

0.35

Correlation Coefficient

HLB Pharmaceutical  Korean Drug

Weak diversification

The 3 months correlation between HLB and Korean is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding HLB Pharmaceutical Co and Korean Drug Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Korean Drug and HLB Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HLB Pharmaceutical Co are associated (or correlated) with Korean Drug. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Korean Drug has no effect on the direction of HLB Pharmaceutical i.e., HLB Pharmaceutical and Korean Drug go up and down completely randomly.

Pair Corralation between HLB Pharmaceutical and Korean Drug

Assuming the 90 days trading horizon HLB Pharmaceutical Co is expected to under-perform the Korean Drug. In addition to that, HLB Pharmaceutical is 3.53 times more volatile than Korean Drug Co. It trades about -0.06 of its total potential returns per unit of risk. Korean Drug Co is currently generating about -0.16 per unit of volatility. If you would invest  508,000  in Korean Drug Co on September 14, 2024 and sell it today you would lose (63,000) from holding Korean Drug Co or give up 12.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

HLB Pharmaceutical Co  vs.  Korean Drug Co

HLB Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days HLB Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Korean Drug

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Korean Drug Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with HLB Pharmaceutical and Korean Drug

The main advantage of trading using opposite HLB Pharmaceutical and Korean Drug positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HLB Pharmaceutical position performs unexpectedly, Korean Drug can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Korean Drug will offset losses from the drop in Korean Drug's long position.

The idea behind HLB Pharmaceutical Co and Korean Drug Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.